TREATED AS CONSUMPTION: HERE NOW, GONE TOMORROW ACTUALLY, A DURABLE GOOD: LONG-LASTING VALUE.

Slides:



Advertisements
Similar presentations
Health Care Costs Joseph P. Newhouse. Main Points The US is an outlier in how much it spends but not its rate of increase Medical advances represent the.
Advertisements

Episode-Based Price Indexes: Plans and Progress Ana Aizcorbe Nicole Nestoriak BEA Advisory Committee Meeting May 4, 2007.
International Variations in Health Care Expenditure Todd Gilmer, PhD Professor of Health Policy and Economics Department of Family and Preventive Medicine.
Peterson-Kaiser Health System Tracker How much does the U.S. spend to treat different diseases?
Your Money or Your Life David M. Cutler Harvard University.
Grinols and Mustard Impact of a casino opening on crime rates Concern: casinos are not random – opened in struggling areas Data at county/year level –

“Insuring Consumption against Illness,” Gertler, P. and J. Gruber(2002)
Economic Challenges and New Medical Technologies Laurence Baker, Ph.D. Stanford University School of Medicine
Change Matters: A Dynamic Demand for Medical Care Jennifer L. Kohn Agenda: 1. Motivation 2. Literature & Contribution 3. Model.
Gender Competency Training for Medical Educators 28 th of April 2003 Evidence of gender difference and its clinical significance Ann-Maree Nobelius Faculty.
Kenneth Sisco, MD, PhD, FCAP Medical Director Quest Diagnostics
The Other Side of Health Care Costs: Is improved technology making a difference? Health care costs have increased dramatically over the past decade - largely.
The Contribution of Health Economics to Health in the United States Mark McClellan, MD, PhD Brookings Institution.
Variation in the Delivery of Medical Care: Is More Better? Todd Gilmer, PhD Professor of Health Policy and Economics Department of Family and Preventive.
The Potential Economic Impact of 3-Share Programs in Texas Texas Communities Healthcare Coalition Presented by TXP & RH2 | November 7, 2008.
November 04, 2008 The Price of Medical Technology: The Industry Perspective David H. Nexon Senior Executive Vice President.
Technology © Allen C. Goodman, 2013 Introduction Start with a typical production relationship of: Q = f (K, L) Ignoring returns to scale, or anything.
Elizabeth Docteur European Health Forum Gastein 7 October 2004 Towards High-Performing Health Systems: Challenges and Opportunities for Reform.
 Copy: few empirical studies compared to other treatments  Eysenck- reviewed 2 studies, incorporating waiting list controls, which showed that 66% of.
Economics Update October 27, New housing starts rose.5% Building permits down Existing home sales up 4% National Associate of Realtors –Existing.
A Satellite Account of U.S. Health Care Spending: Plans and progress Brian C. Moyer Associate Director for Industry Accounts 12 th OECD-NBS Workshop on.
Single-payer Health Care By: Devon Bradley vermont-wants-to-bring-single-payer-to-america
Free Slides from Ed Dolan’s Econ Blog The Economics of a Soda Tax Created April 13, 2010
A Price Deflator for Medical Care Ana Aizcorbe (BEA) Nicole Nestoriak (BLS) 2008 World Congress on National Accounts and Economic Performance Measures.
Cost-effectiveness of pneumococcal vaccination for older people: a study in five western European countries Ament A, Baltussen R, Duru G, Rigaud-Bully.
Growth in prescription spending had slowed, but increased rapidly in 2014 and 2015 Average annual growth rate of prescription drug spending per capita.
Peterson-Kaiser Health System Tracker How has diabetes care in the U.S. changed over time?
Topics in Medical Economics: Health Care Rationing by Joseph Bernstein J Bone Joint Surg Am Volume 88(11): November 1, 2006 ©2006 by The Journal.
Source: Kaiser Family Foundation analysis of National Health Expenditure (NHE) Historical ( ) data from Centers for Medicare and Medicaid Services,
Introducing the New BEA Health Care Satellite Account Abe Dunn, Lindsey Rittmueller, and Bryn Whitmire SEM Conference, Paris 24 July 2015.
Source: National Association of Health Underwriters Education Foundation Value-based Insurance Design 1.
Peterson-Kaiser Health System Tracker What are the recent and forecasted trends in prescription drug spending?
©The Hospital & Healthsystem Association of Pennsylvania The Economic Impact of Pennsylvania’s Hospitals 2016 Analysis.
A one-year audit of topics and domains in the Journal of the American Medical Association and the New England Journal of Medicine1  Steven H Woolf, MD,
Growth in prescription spending had slowed, but increased rapidly in 2014 and 2015
Value of Pharmaceuticals in Managed Care Pharmacy
Figure 4 Progression-free survival, according to treatment group
Amphitheater Public Schools
Value of Pharmaceuticals in Managed Care Pharmacy
Value of Pharmaceuticals in Managed Care Pharmacy
Most Important Issues in Elections
Operationalizing Inclusion
Health and Disease Management
Number of local authorities (LAs) commissioning each service directly or indirectly (n=148) (*Flu vaccination data excludes the service commissioned across.
Primary care physicians visited chiefly by black patients were more likely to report they were unable to provide high-quality care to all their patients.
What It Is and Why It Matters
Townsend profile of heart age tool users showing a similar distribution to that from Census data for England, suggesting good representativeness of the.
Tax Subsidy for Employer Provided Insurance Insurance Option Marginal Product of Labor Insurance Provided by Employer Pre-tax Income (20% tax.
Growth in prescription spending had slowed, but increased rapidly in 2014 and 2015
States with the largest percentage of white residents have the highest Medicare quality rankings. Percentage of population that is non-Hispanic white according.
Baseline Characteristics
Bruce Guthrie Professor of General Practice
Skin in the Game: How Putting Yourself First Today Will Revolutionize Healthcare Tomorrow —John Hammergren (CEO, McKesson) & Phil Harkins.
Bruce Guthrie Professor of General Practice
Glycated Hemoglobin Levels (A1C)
Benefits of Physical Activity “JUMP” !
Previously Uninsured Medicare Beneficiaries with History of Cardiovascular Disease or Diabetes Have Much Higher Self-Reported Hospital Admissions After.
Flow chart of the cohort selection for the study
Distribution of total possible savings (y-axis), showing how much total saving there would be if only those over £x per practice per month (x-axis) were.
Occupational Life Expectancy in England & Wales,
Proportions of discharge diagnoses or death following first readmission/death within 30 or 180 days after initial discharge, according to the presence.
Additional spending needed to close the 2020 mortality gap.
Number of patients treated at clinics that followed up fewer than 10 patients (2013–2016) or 20 patients (2012) and proportion of patients followed up.
Percentage of individuals aged 16 and over taking cardiovascular-related prescriptions, by sex, England 2012–2013. Percentage of individuals aged 16 and.
Value of Pharmaceuticals in Managed Care Pharmacy
Factors associated with preparedness competency of public health inspectors from the qualitative analysis, which are grouped into three levels according.
Overview of the strength of evidence of non-pharmacological and pharmacological interventions compared with inactive interventions for the treatment of.
Distribution of product medicinal products without commercial interest (MPWCI) presentations (original list) studied due to the age of the marketing authorisation.
Twice daily regimen N=45 MDI regimen N=28 P Value
Presentation transcript:

TREATED AS CONSUMPTION: HERE NOW, GONE TOMORROW ACTUALLY, A DURABLE GOOD: LONG-LASTING VALUE

 The Value of Health and Longevity The Value of Health and Longevity Murphy & Topel National Bureau of Economic Research, 2005  The Value of Medical Spending in the US The Value of Medical Spending in the US Cutler et al New England Journal of Medicine, 2002  Are Medical Prices Declining: Evidence from Heart Attack Treatments Are Medical Prices Declining: Evidence from Heart Attack Treatments Cutler & McClellan Quarterly Journal of Economics, 1998